Two-year results for an ultra-low-profile, fixed-wire, sirolimus-eluting coronary stent show no signs of the high target-vessel MI rates that resulted in the OPTIMIZE trial’s failure to demonstrate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results